FDA product code QWT: Prognostic Assessment Software Of Mild Cognitive Impairment
QWT is the FDA product code for prognostic assessment software of mild cognitive impairment. It is a Class II device, regulated under 21 CFR 882.1454 and reviewed by the Neurology panel. FDA has cleared 1 510(k) submission under QWT, 1 in the last five years. The average 510(k) review took 129 days (median 129); 129 days on average over the last three years. 1 De Novo request was granted under it.
Definition
Prognostic assessment software of mild cognitive impairment. Prognostic assessment software of mild cognitive impairment is a prescription-only device that combines information from multiple clinical data sources to produce an output indicative of the likelihood that a patient diagnosed with mild cognitive impairment will progress to more severe forms of cognitive impairment, or will develop dementia, such as Alzheimers disease dementia, within a specified period of time. This device is intended for adjunctive use and not intended as a stand-alone diagnostic or prognostic too.
Classification
| Field | Value |
|---|---|
| Device name | Prognostic Assessment Software Of Mild Cognitive Impairment |
| Device class | Class II |
| Regulation | 21 CFR 882.1454 |
| Review panel | NE — Neurology |
| Medical specialty | Neurology |
| Premarket route | 510(k) |
510(k) clearances per year for QWT
| Year | Clearances | Avg. review days |
|---|---|---|
| 2026 | 1 | 129 |
Compare with all 510(k) review times · Search every QWT clearance
Top QWT applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Neuroxt, Inc. | 1 | 2026-10-08 |
Most recent QWT clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K261805 | Neuroxt, Inc. | NEXT-Cue | 2026-10-08 | 129 |
Recalls for QWT devices
FDA recall records list no recalls for product code QWT.
Frequently asked questions
What is FDA product code QWT?
QWT is the FDA product code for prognostic assessment software of mild cognitive impairment. It is a Class II device, regulated under 21 CFR 882.1454 and reviewed by the Neurology panel.
What device class is QWT?
Class II, regulation 21 CFR 882.1454. Typical premarket route: 510(k).
How long does a 510(k) take for product code QWT?
Across 1 cleared submissions the average was 129 days from receipt to decision (median 129).
Which companies have the most QWT clearances?
Neuroxt, Inc. (1).
Next steps
- Run an FDA pathway report with predicate devices for product code QWT
- Run a recall and safety report across every QWT manufacturer
- Watch product code QWT for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times